InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

Allogene Therapeutics, Inc.

ALLO Clue Score24
United States Fiscal year ends December CIK 0001737287 Results filed 5 Nov 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

12
Insider
Date
Role
Action
Shares
Price
Amount
Arie Belldegrun
16 May 2024
Director
Buy indirect
1,724,137
$2.90
$5.00M
Geoffrey M. Parker
30 Jan 2024
Chief Financial Officer
Buy
190
$3.60
$683.05
Arie Belldegrun
12 Jan 2022
Director
Buy indirect
155,039
$12.60
$1.95M
Joshua A Kazam
12 Jan 2022
Director
Buy
15,000
$12.60
$189.00K
Arie Belldegrun
4 Jun 2020
Director
Buy indirect
106,382
$47.00
$5.00M
Arie Belldegrun
4 Jun 2020
Director
Buy indirect
40,000
$47.00
$1.88M
TPG Group Holdings (SBS) Advisors, Inc.
15 Oct 2018
10% owner
Buy indirect
675,000
$18.00
$12.15M
Pfizer Inc
15 Oct 2018
10% owner
Buy
55,556
$18.00
$1.00M
Arie Belldegrun
15 Oct 2018
Director
Buy
35,000
$18.00
$630.00K
David D Chang
15 Oct 2018
President and CEO
Buy
40,000
$18.00
$720.00K
Franz B Humer
15 Oct 2018
Director
Buy
30,000
$18.00
$540.00K
Owen N. Witte
15 Oct 2018
Director
Buy
15,000
$18.00
$270.00K
Show all 153 transactions →

What was left out

Form 4 filings counted 244
Amendments (4/A) skipped 3
Filings about a different issuer 0
Unreadable filings 0
Joint filings 8
Sales on a Rule 10b5-1 plan 5
Sales straight out of an exercise 32
Sales at will 98
Transactions with no price 0
Shares from compensation/vesting 102,298,948
Sales filed before the plan box existed 70
History held since 17 Oct 2018